Larvol Delta - cAPPricorn1-A-Phase-2-Trial-of-ALNAPP-in-Patients-With-Cerebral-Amyloid-Angiopathy

mivelsiran (ALN-APP) - Alnylam

http://clinicaltrials.gov/ct2/show/NCT06393712

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next